Skip to main content
Premium Trial:

Request an Annual Quote

Numerate Adds Google to List of Cloud Providers for its Drug Design Platform

Premium

Privately held Numerate has integrated its computational drug design platform with Google Compute Engine — a new service the search provider launched this week that is very similar to Amazon's Elastic Compute Cloud.

Until now, Numerate's drug-design platform, which uses a series of proprietary machine-learning algorithms to produce predictive models for molecular properties of candidate compounds, had been only available on Amazon's infrastructure.

Numerate's algorithms will still run on Amazon, Nigel Duffy, Numerate's chief technology officer, told BioInform in an e-mail. The only difference is that customers now have their pick of cloud power.

"For us the key is that there is another really big player in the market ... [and] as users work to reduce lock-in and allow migration between providers it will create an opportunity for capabilities that provide an abstraction on top of these services," he said.

Furthermore, Duffy noted that Google Compute Engine "provides some different perspectives that will be appropriate for some use cases, [for example] integration with App Engine," which Google launched as an early alternative to the Amazon cloud in 2008.

San Bruno, Calif.-based Numerate, whose business model is based on forming risk-sharing partnerships with pharmaceutical and biotechnology companies and academic groups, has worked with Merck (BI 3/16/2012) and Boehringer Ingelheim (BI 12/9/2011).

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.